Sign in

CIK 0001714899

  • Large accelerated filer

Denali Therapeutics Inc.

Sign in to watch
Ticker
DNLI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
463872213
Phone
+1 650-866-8547
Business address
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$363,678
in 3 filings, $327K under 10b5-1 plans

Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-03 Krognes Steve E. Director Grant or award +6,408 38,202
2026-06-03 Krognes Steve E. Director Grant or award · Stock Option (right to buy) +19,226 19,226
2025-06-03 Krognes Steve E. Director Grant or award +6,037 31,794
2025-06-03 Krognes Steve E. Director Grant or award · Stock Option (right to buy) +18,111 18,111
2025-01-07 Krognes Steve E. Director Sale −3,339 $20.81 $69K 25,757
2024-12-31 Krognes Steve E. Director Sale 10b5-1 −30,000 $20.25 $608K 29,096
2024-09-30 Krognes Steve E. Director Sale 10b5-1 −30,000 $29.03 $871K 29,096
2024-08-20 Krognes Steve E. Director Sale −1,727 $23.79 $41K 32,677
2024-07-01 Krognes Steve E. Director Sale 10b5-1 −29,900 $22.12 $661K 34,504
2024-07-01 Krognes Steve E. Director Sale 10b5-1 −100 $22.80 $2K 34,404
2024-06-13 Krognes Steve E. Director Sale 10b5-1 −688 $21.79 $15K 52,620
2024-05-31 Krognes Steve E. Director Grant or award +5,967 53,308
2024-05-31 Krognes Steve E. Director Grant or award · Stock Option (right to buy) +17,901 17,901
2024-04-01 Krognes Steve E. Director Sale 10b5-1 −92,500 $20.50 $1.9M 47,341
2024-02-13 Krognes Steve E. Director Sale −2,750 $17.29 $48K 139,841
2024-01-05 Krognes Steve E. Director Sale −3,208 $19.43 $62K 142,591
2023-08-21 Krognes Steve E. Director Sale −1,419 $22.60 $32K 145,799
2023-06-01 Krognes Steve E. Director Grant or award +4,216 147,218
2023-06-01 Krognes Steve E. Director Grant or award · Stock Option (right to buy) +12,649 12,649
2023-02-13 Krognes Steve E. Director Sale −2,119 $30.10 $64K 143,002

Page 1 of 4 · 70 trades